BL Agro to invest ₹150 crore in cattle genetics expansion by 2027
The FMCG company will expand Leads Genetics’ IVF, embryo-transfer, pathology and genomics capabilities, targeting production of 15,000 bovine embryos a month by end-2027 and reducing reliance on imported cattle genetics.
What happened
FMCG company BL Agro will invest ₹150 crore in Leads Genetics to expand cattle-breeding, IVF, embryo-transfer, pathology and genomics facilities, aiming to
Key facts
- ₹150 crore investment
- 40 to 60 litres of milk per cow per day expected
- 15,000 embryos per month targeted
- end-2027 production target
- two-day summit
What changed
FMCG company BL Agro will invest ₹150 crore in Leads Genetics to expand cattle-breeding, IVF, embryo-transfer, pathology and genomics facilities, aiming to reduce India’s dependence on imported bovine genetics and produce 15,000 embryos monthly by end-2027.
Why this matters
BL Agro’s move into cattle genetics could strengthen long-term dairy supply resilience and create differentiated sourcing advantages beyond its FMCG portfolio.
What to watch
- Quarterly capital-expenditure disclosures and progress toward the stated ₹150 crore investment by 2027.
- IVF lab commissioning, donor herd additions, field-veterinarian network growth and reported embryo-transfer success rates.
- Evidence of demand contracts with dairy cooperatives, commercial dairies, state governments or livestock-development agencies.
- Pricing of domestic embryos versus imported genetics and any changes in import regulations, quarantine rules or subsidies.
- Reported monthly embryo output trajectory toward 15,000 embryos and utilization of installed capacity.